Australia gets 5th approved Covid-19 vaccine in Novavax

The Novavax vaccine will be available to unvaccinated Australians aged 18 years and older but will not be used as a booster for the 95% of the population aged 16 and older who have already received a vaccine.

Published On 2022-01-23 05:15 GMT   |   Update On 2022-01-23 05:15 GMT
Advertisement

New Delhi: Novavax's Covid-19 vaccine on Thursday became the fifth coronavirus vaccine approved for use in Australia.

The country has ordered 51 million doses of the US-manufactured vaccine, supplied under the brand Nuvaxovid, for its population of 26 million. Pfizer, AstraZeneca and Moderna vaccines are already in use in Australia. Johnson and Johnson's Janssen vaccine is also approved but the government has not bought any.
Advertisement
The Novavax vaccine will be available to unvaccinated Australians aged 18 years and older but will not be used as a booster for the 95% of the population aged 16 and older who have already received a vaccine.
"There are some individuals, notwithstanding a massive take up of vaccination in this country, who have been waiting for Novavax, and it's great that it's finally been approved," said chief regulator John Skerritt, head of the Therapeutic Goods Administration.
"Our dream is we might turn our 95% into a 97 or 98% in this country," Skerritt added.
The protein-based vaccine is to be administered in two doses three weeks apart.
Paul Griffin, associate professor of medicine at Queensland University, said Australia needed to strive to improve an already impressive vaccination rate.
"For a variety of reasons, it seems some have remained reluctant to receive these vaccines thus far so an additional option, based on what is considered perhaps a more traditional platform, is likely to increase our vaccination rate even further," Griffin said.
Tags:    
Article Source : AP

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News